Dec 06, 2018 CNAT Price Target - ETF Channel The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. For the CNAT price target at the top of this page, we present the average CNAT target price across the analysts covering CNAT, as reported in data provided by Zacks Investment Research via Quandl.com.The median CNAT price target (a different metric than the average View %COMPANY_NAME% CNAT investment & stock information. Get the latest %COMPANY_NAME% CNAT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. - CNAT - Stock Price Today - Zacks Zacks Investment Research is releasing its prediction for CNAT based on the 1-3 month trading system that nearly triples the S&P 500. Click here - the CNAT analysis is free » Zacks News for CNAT
For Conatus, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%. On the other hand, the stock currently carries a Zacks Rank of #3.
CNAT: Conatus Pharmaceuticals Inc - Price and Consensus Chart. Get the latest Price and View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks 6 May 2019 Conatus, (CNAT) earnings and revenues lag estimates in the These stocks have the greatest potential to increase in price immediately. 31 Aug 2018 Conatus Pharmaceuticals (CNAT) needs investors to pay close attention to the stock based on moves in the options market lately. 13 Mar 2019 Conatus (CNAT) needs investors to pay close attention to the stock based on moves in the options market lately. CNAT Conatus Pharmaceuticals Inc. daily Stock Chart Zacks. 09:59AM. Penumbra Enrolls First Patient for Study on Coronary Vessels. Zacks. Sep-19-19 10: 19 Aug 2019 The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks
Mar 27, 2019
Are Options Traders Betting on a Big Move in Conatus ...
CNAT - Conatus Pharmaceuticals Summary, Stock Quote and ...
The Zacks Analyst Blog Highlights: Gilead Sciences ... Dec 13, 2018 Conatus Pharmaceuticals Inc. (CNAT) stock price, quote ... Zacks Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue Estimates Conatus (CNAT) delivered earnings and revenue surprises of 16.67% and -48.06%, respectively, for …
CNAT: Conatus Pharmaceuticals Inc - Price and Consensus Chart. Get the latest Price and View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks
28 Dec 2018 Conatus currently carries a Zacks Rank #2 (Buy). Another top-ranked stock in the same sector is Bovie Medical Corp. BVX , sporting a Zacks A CNAT split history review and split-adjusted CAGR. Stock Splits Calendar · CNAT Stock Split History · Preferred Stock Newsletter · CNAT Options Chain · Stock Message Boards Direxion Zacks MLP High Income Index Shares (ZMLP) .